NM_000466.3(PEX1):c.1587+1G>A AND Zellweger syndrome

Clinical significance:Likely pathogenic (Last evaluated: Jun 24, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001212702.1

Allele description [Variation Report for NM_000466.3(PEX1):c.1587+1G>A]

NM_000466.3(PEX1):c.1587+1G>A

Gene:
PEX1:peroxisomal biogenesis factor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q21.2
Genomic location:
Preferred name:
NM_000466.3(PEX1):c.1587+1G>A
HGVS:
  • NC_000007.14:g.92510943C>T
  • NG_008341.1:g.22589G>A
  • NG_008341.2:g.22589G>A
  • NM_000466.3:c.1587+1G>AMANE SELECT
  • NM_001282677.2:c.1587+1G>A
  • NM_001282678.2:c.963+1G>A
  • NC_000007.13:g.92140257C>T
  • NM_000466.2:c.1587+1G>A
Links:
dbSNP: rs1057517469
NCBI 1000 Genomes Browser:
rs1057517469
Molecular consequence:
  • NM_000466.3:c.1587+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001282677.2:c.1587+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001282678.2:c.963+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Zellweger syndrome (ZS)
Synonyms:
Zellweger spectrum disorders
Identifiers:
MONDO: MONDO:0019609; MedGen: C0043459; Orphanet: 912

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001384295Invitaecriteria provided, single submitter
Likely pathogenic
(Jun 24, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders.

Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, Valle D, Gould SJ.

Nat Genet. 1997 Dec;17(4):445-8.

PubMed [citation]
PMID:
9398847

Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations.

Rosewich H, Ohlenbusch A, Gärtner J.

J Med Genet. 2005 Sep;42(9):e58.

PubMed [citation]
PMID:
16141001
PMCID:
PMC1736134
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV001384295.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change affects a donor splice site in intron 8 of the PEX1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 371701). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 27, 2021

Support Center